Subcutaneous Immunoglobulin as Replacement Therapy of Children with Primary Immunodeficiencies

被引：0
|
作者：
Uglova, T. [1 ]
Aleshkevich, S. [1 ]
机构：
[1] Natl Res Ctr Pediat Oncol Hematol & Immunol, Minsk, BELARUS
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
ESID-0356
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [41] Subcutaneous Immunoglobulin Replacement Therapy Experience with Intravenous Preparation
    Ozdemir, Oner
    ASTIM ALLERJI IMMUNOLOJI, 2019, 17 (01): : 28 - 33
  • [42] Immunoglobulin Replacement Therapy for Primary Immunodeficiency
    Sriaroon, Panida
    Ballow, Mark
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (04) : 713 - +
  • [43] Outcomes of a patient support programme for subcutaneous immunoglobulin therapy in patients with primary or secondary immunodeficiencies or chronic inflammatory demyelinating polyneuropathy
    Crispin, Philip
    Henderson, Robert
    Yun, James
    Crosbie, Christina
    Tognarini, David
    Youssef, Sherif
    Barrese, Giulio
    Fleischmann, Simone
    INTERNAL MEDICINE JOURNAL, 2024, 54 (11) : 1827 - 1837
  • [44] Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century
    Moore, Meredith L.
    Quinn, James M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (02) : 114 - 121
  • [45] Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss
    Gur-Cetinkaya, Pinar
    Cagdas-Ayvaz, Deniz Nazire
    Oksuz, Ayca Burcu
    Ertoy, Ayse
    Hayran, Umut
    Ozkan, Feride
    Erol, Meliha
    Tezcan, Ilhan
    TURKISH JOURNAL OF PEDIATRICS, 2018, 60 (03) : 270 - 276
  • [46] EXPERIENCE WITH SUBCUTANEOUS LOADING OF VIVAGLOBIN® OR HIZENTRA® IN PRIMARY IMMUNODEFICIENCY PATIENTS NAIVE TO IMMUNOGLOBULIN REPLACEMENT THERAPY
    Koterba, A.
    Farnan, K.
    Sierra, C.
    Eufrasio, D.
    Stein, M. R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A101 - A101
  • [47] Immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies: impact of infusion method on immunoglobulin-specific perceptions of quality of life and treatment satisfaction
    Mallick, Rajiv
    Hahn, Noemi
    Scalchunes, Christopher
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2025, 21 (01):
  • [48] Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies
    Li, Zhaoyang
    Follman, Kristin
    Freshwater, Ed
    Engler, Frank
    Yel, Leman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
  • [49] Assessment of autoantibodies associated with intravenous immunoglobulin replacement therapy in children with primary immunodeficiency
    Ozer, Murat
    Tekeli, Seher
    Dogan, Selcuk
    Cetin, Sema
    Selen, Ridvan
    Aytekin, Caner
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2024, 100 (05)
  • [50] Consideration of Subcutaneous Immunoglobulin Replacement Therapy in Humoral Immunodeficiency Patients
    Lee, Jason K.
    Betschel, Stephen D.
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (09) : 851 - 852
12345